How are types of shock differentiated via a hemodynamics chart?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemodynamic Differentiation of Shock Types

The most effective way to differentiate types of shock is through hemodynamic parameters including cardiac index, systemic vascular resistance, and pulmonary capillary wedge pressure, which provide distinct patterns for cardiogenic, hypovolemic, distributive, and obstructive shock. 1, 2

Key Hemodynamic Parameters for Shock Classification

  • Cardiac Index (CI): Normal range 2.2-4.0 L/min/m²; reduced in cardiogenic and hypovolemic shock, normal or elevated in distributive shock 1, 2
  • Systemic Vascular Resistance (SVR): Elevated in cardiogenic shock, decreased in distributive shock 1
  • Pulmonary Capillary Wedge Pressure (PCWP): Elevated (>15 mmHg) in cardiogenic shock, decreased in hypovolemic shock 1
  • Central Venous Pressure (CVP): Elevated in cardiogenic and obstructive shock, decreased in hypovolemic shock 1

Hemodynamic Patterns in Different Shock Types

Cardiogenic Shock

  • CI: Decreased (<2.2 L/min/m²) 1
  • SVR: Increased (compensatory mechanism) 1
  • PCWP: Elevated (>15 mmHg) 1
  • Clinical presentation: Hypotension (SBP <90 mmHg), signs of hypoperfusion, pulmonary congestion 1
  • Additional hemodynamic markers: Cardiac power output ([CO × MAP]/451) <0.6 W, shock index (HR/systolic BP) >1.0 1

Hypovolemic Shock

  • CI: Decreased 3
  • SVR: Increased (compensatory) 3
  • PCWP: Decreased 1
  • CVP: Decreased 1
  • Clinical presentation: Hypotension, tachycardia, poor peripheral perfusion, decreased urine output 4

Distributive Shock (including Septic Shock)

  • CI: Normal or increased 1
  • SVR: Decreased 1
  • PCWP: Normal or decreased 1
  • Clinical presentation: Hypotension, warm extremities (early), increased lactate 1

Obstructive Shock

  • CI: Decreased 3
  • SVR: Increased 3
  • CVP: Elevated 3
  • Right ventricular parameters: In right ventricular shock, pulmonary artery pulse index [(PASP-PADP)/CVP] <1.0, CVP >15 mmHg, CVP-PCW >0.6 1
  • Clinical presentation: Hypotension, signs of specific obstruction (e.g., tension pneumothorax, cardiac tamponade) 3

SCAI Classification for Cardiogenic Shock

The Society for Cardiovascular Angiography and Interventions (SCAI) classification provides a standardized staging system for cardiogenic shock 1:

  • Stage A (At risk): Normal hemodynamics, normotensive, clear lungs, normal perfusion 1
  • Stage B (Beginning shock): Hypotension (SBP <90 mmHg), normal perfusion, preserved renal function 1
  • Stage C (Classic shock): Hypotension, hypoperfusion, altered mental status, decreased urine output, respiratory distress 1
  • Stage D (Deteriorating): Worsening of Stage C parameters despite interventions 1
  • Stage E (Extremis): Cardiac arrest, refractory hypotension/hypoperfusion, requiring CPR 1

Practical Application of Hemodynamic Monitoring

  • Initial assessment: Evaluate blood pressure, heart rate, peripheral perfusion, urine output, mental status, and lactate levels 2
  • Non-invasive monitoring: Echocardiography provides rapid assessment of cardiac function, volume status, and potential obstructive causes 5
  • Invasive monitoring: Arterial line for continuous blood pressure, pulmonary artery catheter or other advanced hemodynamic monitoring for CI, SVR, and filling pressures when shock is refractory to initial treatment 1, 6

Clinical Pitfalls in Hemodynamic Assessment

  • Mixed shock states: Patients may present with features of multiple shock types, particularly in septic shock with myocardial depression 7
  • Dynamic changes: Hemodynamic parameters can change rapidly as shock progresses or responds to treatment 1
  • Misinterpretation of isolated parameters: Single measurements should not be used in isolation; trends and clinical context are essential 8
  • Delayed recognition: Relying solely on blood pressure can delay recognition of shock; tissue perfusion markers should be evaluated concurrently 6

Hemodynamic-Guided Treatment Approach

  • Cardiogenic shock: Inotropic support (dobutamine, milrinone) for low CI with normal BP; vasopressors (norepinephrine) for hypotension; mechanical circulatory support for refractory cases 1, 2
  • Hypovolemic shock: Fluid resuscitation with balanced crystalloids 3
  • Distributive shock: Combination of vasopressors and fluid replacement 3
  • Obstructive shock: Immediate intervention to relieve obstruction (e.g., pericardiocentesis for tamponade) 3

By systematically evaluating these hemodynamic parameters, clinicians can rapidly identify the type of shock and initiate appropriate treatment strategies to improve outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cardiogenic Shock Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Nomenclature, Definition and Distinction of Types of Shock.

Deutsches Arzteblatt international, 2018

Research

Pathophysiology of shock.

Critical care nursing clinics of North America, 1990

Guideline

Initial Management of Cardiogenic Shock Due to Myocarditis in Pediatrics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Physiopathology of shock.

Journal of emergencies, trauma, and shock, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.